PD5-1-2: A phase I/II study of concurrent hypofractionated chemoradiotherapy using concomitant boost by 3D-conformal or intensity modulated radiotherapy for patients with stage III non-small cell lung cancer: preliminary results of Korean Radiation Oncology Group (KROG) Study- 0301